In kidney cancer, overexpression of GPD1 downregulated various lipid synthesis genes, leading to a decrease in lipid droplets17, the enrichment of which is a characteristic and cancer-requiring feature of ccRCC136–138. This evidence concerns the gene GPD1 and kidney cancer.